These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23722543)

  • 1. Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.
    Le Mercier I; Poujol D; Sanlaville A; Sisirak V; Gobert M; Durand I; Dubois B; Treilleux I; Marvel J; Vlach J; Blay JY; Bendriss-Vermare N; Caux C; Puisieux I; Goutagny N
    Cancer Res; 2013 Aug; 73(15):4629-40. PubMed ID: 23722543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
    Sisirak V; Faget J; Gobert M; Goutagny N; Vey N; Treilleux I; Renaudineau S; Poyet G; Labidi-Galy SI; Goddard-Leon S; Durand I; Le Mercier I; Bajard A; Bachelot T; Puisieux A; Puisieux I; Blay JY; Ménétrier-Caux C; Caux C; Bendriss-Vermare N
    Cancer Res; 2012 Oct; 72(20):5188-97. PubMed ID: 22836755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
    Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
    Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.
    Sisirak V; Vey N; Goutagny N; Renaudineau S; Malfroy M; Thys S; Treilleux I; Labidi-Galy SI; Bachelot T; Dezutter-Dambuyant C; Ménétrier-Caux C; Blay JY; Caux C; Bendriss-Vermare N
    Int J Cancer; 2013 Aug; 133(3):771-8. PubMed ID: 23389942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine thymic plasmacytoid dendritic cells.
    Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
    Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
    Labidi-Galy SI; Sisirak V; Meeus P; Gobert M; Treilleux I; Bajard A; Combes JD; Faget J; Mithieux F; Cassignol A; Tredan O; Durand I; Ménétrier-Caux C; Caux C; Blay JY; Ray-Coquard I; Bendriss-Vermare N
    Cancer Res; 2011 Aug; 71(16):5423-34. PubMed ID: 21697280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids.
    Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F
    Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.
    Romagnani C; Della Chiesa M; Kohler S; Moewes B; Radbruch A; Moretta L; Moretta A; Thiel A
    Eur J Immunol; 2005 Aug; 35(8):2452-8. PubMed ID: 15997468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
    Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
    Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.
    Davidson S; Kaiko G; Loh Z; Lalwani A; Zhang V; Spann K; Foo SY; Hansbro N; Uematsu S; Akira S; Matthaei KI; Rosenberg HF; Foster PS; Phipps S
    J Immunol; 2011 May; 186(10):5938-48. PubMed ID: 21482736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
    Guillerme JB; Boisgerault N; Roulois D; Ménager J; Combredet C; Tangy F; Fonteneau JF; Gregoire M
    Clin Cancer Res; 2013 Mar; 19(5):1147-58. PubMed ID: 23339127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.
    Guiducci C; Coffman RL; Barrat FJ
    J Intern Med; 2009 Jan; 265(1):43-57. PubMed ID: 19093959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.
    Núñez NG; Andreani V; Crespo MI; Nocera DA; Breser ML; Morón G; Dejager L; Libert C; Rivero V; Maccioni M
    Cancer Res; 2012 Feb; 72(3):592-603. PubMed ID: 22139376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.
    Edwards AD; Diebold SS; Slack EM; Tomizawa H; Hemmi H; Kaisho T; Akira S; Reis e Sousa C
    Eur J Immunol; 2003 Apr; 33(4):827-33. PubMed ID: 12672047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
    Hamm S; Rath S; Michel S; Baumgartner R
    J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
    Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
    J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.